EUVIMEDEUVIMED entdecken
Crossref

Lower prevalence of anti‐HTLV‐1 as expected by previous models among first‐time blood donors in Japan

Masahiro Satake iD, Yasuko Sagara, Isao Hamaguchi

Journal of Medical Virology · 2023-03 · 95 (3)

DOI: 10.1002/jmv.28606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 02.03.2023. Verfasst von Masahiro Satake und 2 weiteren Autor:innen. Beteiligte Einrichtung: Japanese Red Cross Central Blood Institute, Tokyo, Japan. Hauptthemen laut MEDLINE: Human T-lymphotropic virus 1, HTLV-I Infections. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An estimated 1.08 million carriers of human T‐lymphotropic virus 1 (HTLV‐1) were living in Japan in 2006–2007. Since that study, new data on horizontal infection, nationwide antenatal screening for anti‐HTLV‐1 in pregnant women, and social educational campaigns on HTLV‐1 infection have emerged in Japan. To estimate the current number of HTLV‐1 carriers in Japan, confirmed HTLV‐1 infections among first‐time blood donors in 2020–2021 from across Japan were investigated. Age‐, sex‐ and geographic area‐specific information associated with HTLV‐1 antibody detection was evaluated. Data obtained were compared with predictions based on 2006–2007 data, considering a birth cohort effect that assumed lifelong maintenance of seropositivity. HTLV‐1 seroprevalence in women was almost equivalent to that in men. The prevalence in men was similar to that predicted from 2006 to 2007 data. In contrast, the prevalence in women was lower in all age strata than that predicted by each birth cohort. The estimate for the entirety of Japan was 534 000 carriers from measured prevalence, whereas that from the birth cohort effect‐adjusted prevalence was 658 000. The number of HTLV‐1 carriers in Japan was estimated to have decreased by approximately 40% during the past 14 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human T-lymphotropic virus 1HTLV-I InfectionsMaleFemaleHumansPregnancyJapanBlood DonorsPrevalenceSeroepidemiologic Studies

Stichwörter der Autor:innen

anti-HTLV-1blood donorhorizontal infectionprevalence

Autor:innen und Institutionen

  • Japanese Red Cross Central Blood Institute, Tokyo, Japan.
  • Japanese Red Cross Kyushu Block Blood Centre, Kurume, Japan.
  • National Institute of Infectious Diseases, Tokyo, Japan.

ORCID-Profile: Masahiro Satake

Zitieren

APA

Satake, M., Sagara, Y., & Hamaguchi, I. (2023). Lower prevalence of anti‐HTLV‐1 as expected by previous models among first‐time blood donors in Japan. Journal of Medical Virology, 95(3). https://doi.org/10.1002/jmv.28606

Vancouver

Satake M, Sagara Y, Hamaguchi I. Lower prevalence of anti‐HTLV‐1 as expected by previous models among first‐time blood donors in Japan. Journal of Medical Virology. 2023;95(3). doi:10.1002/jmv.28606

BibTeX
@article{Satake2023,
  author = {Satake, Masahiro and Sagara, Yasuko and Hamaguchi, Isao},
  title = {Lower prevalence of anti‐HTLV‐1 as expected by previous models among first‐time blood donors in Japan},
  journal = {Journal of Medical Virology},
  year = {2023},
  volume = {95},
  number = {3},
  doi = {10.1002/jmv.28606}
}
Kostenlos starten →